It is a trading private limited company based in Giddarbaha, Punjab, India, established in 2006.
2006 | Giddarbaha, Punjab, India | ActiveDenovo Pharmaceuticals Private Limited, a active private limited company, was established on 19 December 2006 in Giddarbaha, Punjab, India. Engaging in other wholesale within the trade sector, it holds CIN: U24232PB2006PTC030764. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.60 M and a paid-up capital of ₹0.60 M.
It upholds a active non-compliant status. Its leadership includes Manish Garg (Director), Sanjeev Kumar Garg (Director), Deepak Garg (Director). Past directors included Raj Kumar Garg, Manoj Garg, Thaneshvar Garg. It holds ₹3.50 M open charges and no settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at C/O Daya Kutir, Ward No. 2, Denovo Marg, Roopnagar Faridkot, Giddarbaha, Punjab, 152026.
U24232PB2006PTC030764
030764
19 December 2006
₹0.60 M
₹0.60 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Denovo Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manish Garg | Director | 20 Jul 2017 | Current |
| Sanjeev Kumar Garg | Director | 01 Jul 2011 | Current |
| Deepak Garg | Director | 31 Mar 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jul 2011 | Past |
| Pramod Abcsdd | Director | 04 Dec 2019 | Past |
| Pramod Abcsdd | Director | 01 Apr 2009 | Past |
| Pramod Abcsdd | Director | 28 Apr 2015 | Past |
| Pramod Abcsdd | Director | 26 Mar 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Denovo Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Denovo Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Sep 2012 | State Bank Of Patiala | ₹3.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Denovo Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Denovo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Denovo Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Denovo Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.
Progress on Denovo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Chandigarh. was documented.
Progress on Manish Garg was appointed as a Director was appointed as a Director on 20 Jul 2017 & has been associated with this company since 8 years 4 months . was documented.
Progress on Deepak Garg was appointed as a Director was appointed as a Director on 31 Mar 2015 & has been associated with this company since 10 years 8 months . was documented.
Progress on A charge with State Bank Of Patiala of Rs. 3.50 M registered on 28 Sep 2012 with Charge ID 10382591 was modified on 22 Oct 2014. was documented.
Progress on A charge with State Bank Of Patiala amounted to Rs. 3.50 M with Charge ID 10382591 was registered on 28 Sep 2012. was documented.
The CIN of Denovo Pharmaceuticals Private Limited is U24232PB2006PTC030764.
Denovo Pharmaceuticals Private Limited is headquartered at C/O Daya Kutir, Ward No. 2, Denovo Marg, Roopnagar Faridkot, Giddarbaha, Punjab, 152026.
Denovo Pharmaceuticals Private Limited was incorporated on 19 December 2006.
The current directors of Denovo Pharmaceuticals Private Limited are
The primary industry of Denovo Pharmaceuticals Private Limited is Trade.
Denovo Pharmaceuticals Private Limited is unlisted.
The authorized capital of Denovo Pharmaceuticals Private Limited is ₹0.60 M, and the paid-up capital is ₹0.60 M.
The compliance status of Denovo Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX